BBDC Research Update: Women's Health, Pregnancy, and Osteogenesis Imperfecta (OI)

On June 24, 2021 Tracy Hart, CEO of the OI Foundation, and Dr. Deborah Krakow, OIF Medical Advisory Council (MAC) member, discussed women's health and pregnancy research.

This conversation is part of a series highlighting the work of the Brittle Bone Disorders Consortium (BBDC), a multi-center program that focuses on understanding and providing better treatment options for all types of osteogenesis imperfecta (OI). The BBDC is part of the National Institute of Health's (NIH) Rare Diseases Clinical Research Network (RDCRN) and contains sites around the US and Canada.

Learning Objectives

The learning objectives for all the BBDC Research Updates are to
-Highlight the work of the BBDC and individual research projects within it.
-Learn more about the process of OI research.

Scientific concepts and research design
Medicines development and regulation
Clinical trial operations
Brittle Bone Disorders Consortium (BBD)
Time Required
1 hour
On demand
Delivery Method
Date Created

Submitted by Michael Stewart on Thu, 12/16/2021 - 16:40 . Last modified on 12/17/2021